Notes From the Editor Emeritus, 2020–2021

Deoxyribose sugar gel is discussed as a potential hair loss treatment, but it lacks human trials and credible evidence. Users express skepticism and humor about its effectiveness compared to established treatments like minoxidil and finasteride.

The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.

The user experienced hair loss starting in 2020-21, with significant thinning by 2024. They used finasteride, dutasteride, and oral minoxidil, seeing regrowth initially but faced setbacks due to medication interruptions and other factors, leading to thinning again.

A trans male shared his 3.5-year experience using finasteride for hair loss, noting improvements in hair density and hairline thickness without using minoxidil due to health concerns. He also uses Tołpa Torf shampoos and scalp serums, and emphasizes the importance of mental health and self-image in his journey.

The conversation discusses the effects of finasteride on hair loss and its potential neurological and sexual side effects. Users share personal experiences, with some reporting positive outcomes and others expressing concerns about cognitive function.

A user experienced erectile issues after 7 months of using Finasteride and sought advice. Responses varied, with some suggesting breaks and others sharing similar side effects or dismissing concerns.